PillRx only · Capsule · Oral
Loxapine
Loxapine Succinate
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.570
Latest avg · Jul 22, 2026
+10%
Since Dec 17, 2025
7
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
13K
Rx · 2026 Q1
822K
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Lannett Company, Inc. | unknown | 8 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 7 | SUPPLYING |
| Elite Laboratories, Inc | unknown | 4 | SUPPLYING |
| Proficient Rx LP | unknown | 3 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 3 | SUPPLYING |
| Coupler LLC | unknown | 3 | SUPPLYING |
| Chartwell RX, LLC | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.